Title : The prostacyclin pathway in pulmonary arterial hypertension: a clinical review.

Pub. Date : 2017 Jun

PMID : 28399721






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 INTRODUCTION: Prostacyclin is produced in vascular endothelial cells and acts via the IP prostacyclin receptor to cause vasodilation and inhibit smooth muscle cell proliferation and platelet aggregation. Epoprostenol prostaglandin I2 receptor Homo sapiens
2 The newest agent targeting the prostacyclin pathway, the selective prostacyclin receptor agonist selexipag, is administered orally, and has been shown to reduce a composite morbidity/mortality endpoint. Epoprostenol prostaglandin I2 receptor Homo sapiens